search
Back to results

Brief Cognitive Behavioral Therapy for Chronic Pain to Improve Functioning Among Veterans

Primary Purpose

Musculoskeletal Pain, Pain

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Brief CBT for Chronic Pain
Treatment as usual
Sponsored by
VA Office of Research and Development
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Musculoskeletal Pain focused on measuring primary care, chronic pain, cognitive behavioral therapy, integrated primary care, musculoskeletal pain

Eligibility Criteria

18 Years - 79 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Veterans age >=18 and <=79 years
  • Conversant in English
  • A diagnosis of musculoskeletal pain of >three months
  • PEG score of >= 4 on pain intensity item and both interference items at screening
  • BPI interference and pain intensity score of at least 4.0 at baseline
  • If currently prescribed pain medication (other than topicals or NSAIDS), a stable dose in the last two months
  • If currently prescribed psychiatric medicine, a stable dose in the last two months
  • Established history of VA primary care utilization (i.e., at least one primary care visit in the past year)

Exclusion Criteria:

  • Current or prior (past 12 months) engagement in psychotherapy or behavioral intervention provided by behavioral medicine services or specialty mental health for chronic pain.

    • Medication management through psychiatric services or an on-going course of mental health services for issues other than chronic pain are not excluded.
  • Endorsement of imminent suicide risk
  • Current significant substance use problems (i.e., alcohol, opioids, benzodiazepines, or other drugs)
  • Unstable psychiatric status (e.g., active psychosis, current mania)
  • Diagnosed with major or minor neurocognitive disorder
  • Unwilling to have treatment sessions audio recorded
  • Pending disability claim
  • Recent or planned surgical/interventional procedure for pain

Sites / Locations

  • VA Western New York Healthcare System, Buffalo, NYRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

Brief CBT for Chronic Pain and treatment as usual

Treatment as usual only

Arm Description

Participants will receive Brief CBT-CP in addition to usual primary care treatment. Brief CBT-CP is a manualized protocol that includes six, 30-minute sessions over the course of 6-12 weeks. Session one focuses on foundational pain education and the development of treatment goals. Session two emphasizes balanced engagement in physical activity and pleasurable events. Session three emphasizes skills training for easily implemented relaxation techniques. Sessions four and five focus on recognizing and modifying unhelpful thoughts that negatively impact pain. Session six focuses on relapse prevention and independent implementation of CBT-CP skills following treatment.

Participants assigned to treatment as usual will receive standard medical care from their primary care provider including pain medications, brief advice (e.g., use of relative rest, application of heat or ice, other self-care strategies), or referral to pain-related adjunctive interventions (e.g., physical therapy), as indicated.

Outcomes

Primary Outcome Measures

Brief Pain Inventory -- Interference subscale (BPI-I) to assess change at 12 week follow-up
This measure is a validated 7-item subscale that evaluates pain-related interference in daily activities and social and occupational functioning. Average scores range from 0 to 10, with higher scores indicating higher pain-related interference.

Secondary Outcome Measures

Brief Pain Inventory -- Pain Intensity subscale (BPI-P) to assess change at 12 week follow-up
This measure is a validated 4-item subscale that evaluates pain intensity. Average scores range from 0 to 10, with higher scores indicating worse pain intensity.
Patient Health Questionnaire -- 9 (PHQ-9) to assess change at 12 week follow-up
This 9-item measure of depressive symptoms is validated for use in primary care. Total scores range from 0 to 27, with higher scores indicating more depression symptoms.
Scale for Suicide Ideation (SSI) to assess change at 12 week follow-up
This measure is 21-items and rates current attitudes, behaviors, and plans to commit suicide. Average scores range from 0 to 38, with higher scores indicating higher intensity of suicidal ideation.
World Health Organization Quality of Life - BREF (WHOQOL-BREF) to assess change at 12 week follow up
This 26-item abbreviated version of the full-length WHOQOL measure evaluates quality of life in several domains such as social relationships and satisfaction with person-environment interactions. Scoring is by subscales representing four domains (i.e., physical health, psychological, social relationship, and environment). Transformed mean scores for each domain range from four to 20, with higher scores indicating greater quality of life in the respective domain.
Ability to Participate in Social Roles and Activities - short form (APSRA) to assess change at 12 week follow up
This 8-item measure was developed to evaluate one's perceived ability to perform usual social roles and activities. Total scores range from eight to 40, with higher scores indicating better ability to participate in usual activities.

Full Information

First Posted
January 14, 2021
Last Updated
August 23, 2023
Sponsor
VA Office of Research and Development
search

1. Study Identification

Unique Protocol Identification Number
NCT04724694
Brief Title
Brief Cognitive Behavioral Therapy for Chronic Pain to Improve Functioning Among Veterans
Official Title
Brief Cognitive Behavioral Therapy for Chronic Pain to Improve Functional Outcomes amongPrimary Care Veterans
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 1, 2021 (Actual)
Primary Completion Date
September 30, 2024 (Anticipated)
Study Completion Date
September 30, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
VA Office of Research and Development

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Chronic pain is very common among primary care Veterans and can seriously impact overall patient functioning and well-being. Currently, behavioral treatments for pain management are not often provided in primary care because they are designed to be delivered in specialty care settings, such as chronic pain clinics. To address this gap in care, the proposed study will test if Brief Cognitive Behavioral Therapy for Chronic Pain (Brief CBT-CP) is an effective treatment. Therefore, the first objective of the proposed study is to conduct a randomized controlled trial of Brief CBT-CP compared to primary care treatment as usual to assess treatment effectiveness by examining changes in pain-related physical activity interference, psychological distress, pain intensity, and other related outcomes. 178 eligible participants will be randomized into either Brief CBT-CP and primary care treatment as usual or primary care treatment as usual only. Eligible Veterans will include those with chronic musculoskeletal pain and pain-related functional impairment identified from primary care. Participants assigned to Brief CBT-CP will receive six sessions of treatment in 30-minute appointments. This intervention will include education and goal setting, activities and pacing, relaxation skills, cognitive coping, and relapse prevention. Assessments will include validated self-report measures that will take place at pre-treatment (baseline), mid-treatment, post-treatment, and at 6-month follow-up. The second objective of this study is examine the mechanisms by which Brief CBT-CP leads to improvement in patient outcomes. Statistical analysis will reveal if changes pain self-efficacy (i.e., perceived ability to manage pain or engage in usual activities despite being in pain) and catastrophizing (i.e., unhelpful, negative though patterns about pain and pain management) lead to improvements in patient functioning. The third objective of this study will be to explore perceptions of Brief CBT-CP among patients who experience significant improvement in outcomes compared to those who did not experience improvement. Participants will include up to 40 patients who were treated with Brief CBT-CP. Participants will be interviewed about key components of the treatment and their perception of effectiveness. Interview data will be compared to the results of statistical analysis to help understand the mechanisms by which Brief CBT-CP is effective or identify areas for improvement. Results of this study will provide information needed to determine if Brief CBT-CP should be widely disseminated across VA primary care clinics.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Musculoskeletal Pain, Pain
Keywords
primary care, chronic pain, cognitive behavioral therapy, integrated primary care, musculoskeletal pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Two arm parallel design: 1) primary care treatment as usual, or 2) primary care treatment as usual and Brief Cognitive Behavioral Therapy for Chronic Pain
Masking
Outcomes Assessor
Masking Description
Only the outcomes assessor will be masked
Allocation
Randomized
Enrollment
178 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Brief CBT for Chronic Pain and treatment as usual
Arm Type
Experimental
Arm Description
Participants will receive Brief CBT-CP in addition to usual primary care treatment. Brief CBT-CP is a manualized protocol that includes six, 30-minute sessions over the course of 6-12 weeks. Session one focuses on foundational pain education and the development of treatment goals. Session two emphasizes balanced engagement in physical activity and pleasurable events. Session three emphasizes skills training for easily implemented relaxation techniques. Sessions four and five focus on recognizing and modifying unhelpful thoughts that negatively impact pain. Session six focuses on relapse prevention and independent implementation of CBT-CP skills following treatment.
Arm Title
Treatment as usual only
Arm Type
Other
Arm Description
Participants assigned to treatment as usual will receive standard medical care from their primary care provider including pain medications, brief advice (e.g., use of relative rest, application of heat or ice, other self-care strategies), or referral to pain-related adjunctive interventions (e.g., physical therapy), as indicated.
Intervention Type
Behavioral
Intervention Name(s)
Brief CBT for Chronic Pain
Other Intervention Name(s)
Brief CBT-CP
Intervention Description
Brief CBT-CP is a manualized protocol that includes six, 30-minute sessions over the course of 6-12 weeks. Session one focuses on foundational pain education and the development of treatment goals. Session two emphasizes balanced engagement in physical activity and pleasurable events. Session three emphasizes skills training for easily implemented relaxation techniques. Sessions four and five focus on recognizing and modifying unhelpful thoughts that negatively impact pain. Session six focuses on relapse prevention and independent implementation of CBT-CP skills following treatment.
Intervention Type
Other
Intervention Name(s)
Treatment as usual
Other Intervention Name(s)
Primary care treatment as usual
Intervention Description
Participants assigned to TAU will receive standard medical care from their primary care provider including pain medications, brief advice (e.g., use of relative rest, application of heat or ice, other self-care strategies), or referral to pain-related adjunctive interventions (e.g., physical therapy), as indicated.
Primary Outcome Measure Information:
Title
Brief Pain Inventory -- Interference subscale (BPI-I) to assess change at 12 week follow-up
Description
This measure is a validated 7-item subscale that evaluates pain-related interference in daily activities and social and occupational functioning. Average scores range from 0 to 10, with higher scores indicating higher pain-related interference.
Time Frame
Baseline, 12-weeks
Secondary Outcome Measure Information:
Title
Brief Pain Inventory -- Pain Intensity subscale (BPI-P) to assess change at 12 week follow-up
Description
This measure is a validated 4-item subscale that evaluates pain intensity. Average scores range from 0 to 10, with higher scores indicating worse pain intensity.
Time Frame
Baseline, 12-weeks
Title
Patient Health Questionnaire -- 9 (PHQ-9) to assess change at 12 week follow-up
Description
This 9-item measure of depressive symptoms is validated for use in primary care. Total scores range from 0 to 27, with higher scores indicating more depression symptoms.
Time Frame
Baseline, 12-weeks
Title
Scale for Suicide Ideation (SSI) to assess change at 12 week follow-up
Description
This measure is 21-items and rates current attitudes, behaviors, and plans to commit suicide. Average scores range from 0 to 38, with higher scores indicating higher intensity of suicidal ideation.
Time Frame
Baseline, 12-weeks
Title
World Health Organization Quality of Life - BREF (WHOQOL-BREF) to assess change at 12 week follow up
Description
This 26-item abbreviated version of the full-length WHOQOL measure evaluates quality of life in several domains such as social relationships and satisfaction with person-environment interactions. Scoring is by subscales representing four domains (i.e., physical health, psychological, social relationship, and environment). Transformed mean scores for each domain range from four to 20, with higher scores indicating greater quality of life in the respective domain.
Time Frame
Baseline, 12-weeks
Title
Ability to Participate in Social Roles and Activities - short form (APSRA) to assess change at 12 week follow up
Description
This 8-item measure was developed to evaluate one's perceived ability to perform usual social roles and activities. Total scores range from eight to 40, with higher scores indicating better ability to participate in usual activities.
Time Frame
Baseline, 12-weeks
Other Pre-specified Outcome Measures:
Title
Pain Self-Efficacy Questionnaire (PSEQ) to assess role in mediation at 12 week follow up
Description
This validated measure includes 10-items related to pain-related self-efficacy, such as accomplishing goals and becoming more active. Total scores range from 0 to 60, with higher scores indicating greater pain-related self-efficacy.
Time Frame
12-weeks
Title
Pain Catastrophizing Scale (PCS) to assess role in mediation at 12 week follow up
Description
This validated 13-item measure assesses pain-related cognitions such as pain magnification and perceived helplessness. Total scores range from 0 to 52, with higher scores indicating higher levels of negative pain-related thoughts
Time Frame
12-weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
79 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Veterans age >=18 and <=79 years Conversant in English A diagnosis of musculoskeletal pain of >three months PEG score of >= 4 on pain intensity item and both interference items at screening BPI interference and pain intensity score of at least 4.0 at baseline If currently prescribed pain medication (other than topicals or NSAIDS), a stable dose in the last two months If currently prescribed psychiatric medicine, a stable dose in the last two months Established history of VA primary care utilization (i.e., at least one primary care visit in the past year) Exclusion Criteria: Current or prior (past 12 months) engagement in psychotherapy or behavioral intervention provided by behavioral medicine services or specialty mental health for chronic pain. Medication management through psychiatric services or an on-going course of mental health services for issues other than chronic pain are not excluded. Endorsement of imminent suicide risk Current significant substance use problems (i.e., alcohol, opioids, benzodiazepines, or other drugs) Unstable psychiatric status (e.g., active psychosis, current mania) Diagnosed with major or minor neurocognitive disorder Unwilling to have treatment sessions audio recorded Pending disability claim Recent or planned surgical/interventional procedure for pain
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Gregory P Beehler, PhD
Phone
(716) 862-7934
Email
Gregory.Beehler@va.gov
First Name & Middle Initial & Last Name or Official Title & Degree
Wade Goldstein, MA
Phone
(716) 862-8901
Email
wade.goldstein@va.gov
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gregory P. Beehler, PhD
Organizational Affiliation
VA Western New York Healthcare System, Buffalo, NY
Official's Role
Principal Investigator
Facility Information:
Facility Name
VA Western New York Healthcare System, Buffalo, NY
City
Buffalo
State/Province
New York
ZIP/Postal Code
14215-1129
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gregory P Beehler, PhD
Phone
716-862-7934
Email
Gregory.Beehler@va.gov
First Name & Middle Initial & Last Name & Degree
Wade Goldstein, MA
Phone
(716) 862-8901
Email
wade.goldstein@va.gov
First Name & Middle Initial & Last Name & Degree
Gregory P. Beehler, PhD

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
A Limited Dataset (LDS) will be created and shared pursuant to a Data Use Agreement (DUA) appropriately limiting use of the dataset and prohibiting the recipient from identifying or re-identifying (or taking steps to identify or re-identify) any individual whose data are included in the dataset. The LDS will contain IPD that underlie results presented in publications.
IPD Sharing Time Frame
IPD will be made available for up to three years starting six months after final publication.
IPD Sharing Access Criteria
Data will be shared upon completion of a written request and within 90 days of a completed Data Use Agreement (DUA).

Learn more about this trial

Brief Cognitive Behavioral Therapy for Chronic Pain to Improve Functioning Among Veterans

We'll reach out to this number within 24 hrs